Response: Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.

Response: Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase.

Expert Opin Pharmacother. 2017 Jan 13;:

Authors: Saydam G

PMID: 28085495 [PubMed - as supplied by publisher]

http://ift.tt/2ji9Wa0